Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HS1371是一种新型高效的 ATP 竞争性受体相互作用蛋白激酶 3 抑制剂,IC50为 20.8 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 398 | 现货 | ||
5 mg | ¥ 942 | 现货 | ||
10 mg | ¥ 1,560 | 现货 | ||
25 mg | ¥ 2,970 | 现货 | ||
50 mg | ¥ 4,390 | 现货 | ||
100 mg | ¥ 6,180 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,090 | 现货 |
产品描述 | HS-1371 is a novel kinase inhibitor of receptor-interacting protein kinase 3 (RIP3) with an IC50 of 20.8 nM. |
靶点活性 | RIP3:20.8 nM |
体外活性 | HS-1371 directly binds to RIP3 in an ATP-competitive and time-independent manner, providing a mechanism of action.?Moreover, the compound inhibited TNF-induced necroptosis but did not inhibit TNF-induced apoptosis, indicating that this novel inhibitor has a specific inhibitory effect on RIP3-mediated necroptosis via the suppression of RIP3 kinase activity.?HS-1371 could serve as a potential preventive or therapeutic agent for diseases involving RIP3 hyperactivation. |
分子量 | 384.47 |
分子式 | C24H24N4O |
CAS No. | 2158197-70-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 16.67 mg/mL (43.36 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.601 mL | 13.0049 mL | 26.0098 mL | 65.0246 mL |
5 mM | 0.5202 mL | 2.601 mL | 5.202 mL | 13.0049 mL | |
10 mM | 0.2601 mL | 1.3005 mL | 2.601 mL | 6.5025 mL | |
20 mM | 0.13 mL | 0.6502 mL | 1.3005 mL | 3.2512 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
HS-1371 2158197-70-5 Apoptosis NF-Κb RIP kinase Inhibitor Receptor-interacting protein kinases HS1371 RIPK inhibit HS 1371 inhibitor